Iruma, Japan

Shingo Sato

This inventor holds 2 USPTO granted patents. Top assignee: Mect Corporation. Active years: 1991-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shingo Sato. Retrieved from https://idiyas.com/inventor/shingo-sato-5vhfy7sr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Shingo Sato

Introduction

Shingo Sato, an accomplished inventor based in Iruma, Japan, has contributed significantly to the field of medical innovations. With a total of two patents to his name, his work primarily focuses on advancements in treatments for nerve-related diseases.

Latest Patents

Among his latest patents is the invention of a sodium salt of sialosyl cholesterol, designed to aid in the treatment of diseases stemming from lesions in peripheral or central nerves. This compound is noted for its high water solubility, enhancing its utility as a medicinal application. Furthermore, he has developed a process for producing sialosyl cholesterol, which adds value to his contributions in neuropathy treatment.

Career Highlights

Shingo Sato is currently associated with Mect Corporation, where he plays a pivotal role in advancing medical sciences through innovative research. His work is invaluable in the ongoing quest to provide effective remedies for debilitating nerve conditions.

Collaborations

In his journey as an inventor, Shingo has collaborated with esteemed colleagues, including Haruo Ogura and Kimio Furuhata. Their combined expertise fosters an environment conducive to breakthroughs in medical research and development.

Conclusion

Shingo Sato stands out as a visionary in the realm of medical inventions, leveraging his patents to forge paths towards enhanced therapeutic options for nerve-related diseases. His contributions underscore the critical intersection of innovation and healthcare, impacting countless lives through improved treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…